The DOI matches its Crossref record; 191 of the 193 references it cites were found in a registry or an index.
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Open accessAbstract
The incidence and prevalence of diabetes mellitus have grown significantly throughout the world, due primarily to the increase in type 2 diabetes. This overall increase in the number of people with diabetes has had a major impact on development of diabetic kidney disease (DKD), one of the most frequent complications of both types of diabetes. DKD is the leading cause of end-stage renal disease (ESRD), accounting for approximately 50% of cases in the developed world. Although incidence rates for ESRD attributable to DKD have recently stabilized, these rates continue to rise in high-risk groups such as middle-aged African Americans, Native Americans, and Hispanics. The costs of care for people with DKD are extraordinarily high. In the Medicare population alone, DKD-related expenditures among this mostly older group were nearly $25 billion in 2011. Due to the high human and societal costs, the Consensus Conference on Chronic Kidney Disease and Diabetes was convened by the American Diabetes Association in collaboration with the American Society of Nephrology and the National Kidney Foundation to appraise issues regarding patient management, highlighting current practices and new directions. Major topic areas in DKD included 1) identification and monitoring, 2) cardiovascular disease and management of dyslipidemia, 3) hypertension and use of renin-angiotensin-aldosterone system blockade and mineralocorticoid receptor blockade, 4) glycemia measurement, hypoglycemia, and drug therapies, 5) nutrition and general care in advanced-stage chronic kidney disease, 6) children and adolescents, and 7) multidisciplinary approaches and medical home models for health care delivery. This current state summary and research recommendations are designed to guide advances in care and the generation of new knowledge that will meaningfully improve life for people with DKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A1C levels are also less reliable at advanced CKD stages (64,65).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“A1C levels are also less reliable at advanced CKD stages (63,64).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [63]
In the citing paper
“There is no evidence that adjusting the daily level of protein intake (typically 1-1.5 g/kg body wt/day or 15-20% total calories) will improve health, and research is inconclusive regarding the ideal amount of dietary protein to optimize either glycemic management or CVD risk (159,195).”
From 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023 (2023) · cites this paper as [195]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedAhmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Self-citationBrenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Adherence to Long-Term Therapies: Evidence for Action
Geest, S. D., & Sabate, E. J. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,310
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Flagged first, then by citations
2 of the 193 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 1,000
Type 2 diabetes mellitus management in patients with chronic kidney disease: an update
Kleinaki, Z., Kapnisi, S., Theodorelou‐Charitou, S., Nikas, I. P., & Paschou, S. Α. (2020) · HORMONES · doi:10.1007/s42000-020-00212-y · Cited by 27
Kowalski, A., Krikorian, A., & Lerma, E. V. (2014) · Europe PMC (PubMed Central) · Cited by 27
Khor, B. Y. C., & Price, P. (2017) · Journal of Foot and Ankle Research · doi:10.1186/s13047-017-0206-5 · Cited by 27
The Roles of Fatty Acids and Apolipoproteins in the Kidneys
Pan, X. (2022) · Metabolites · doi:10.3390/metabo12050462 · Cited by 27
DeFina, L. F., Barlow, C. E., Radford, N. B., Leonard, D. S., & Willis, B. L. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.05.030 · Cited by 28
Yoon, S. A., Han, B. G., Kim, S. G., Han, S. Y., Jo, Y. I., Jeong, K. H., Oh, K.-H., Park, H. C., Park, S. H., Kang, S., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12863 · Cited by 27
Zhang, L., Zhang, M., Lv, Q., & Tong, N. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.047 · Cited by 27
Kong, A. P. S., Lew, T., Lau, E. S. H., Lim, L., Kesavadev, J., Jia, W., Sheu, W. H., Sobrepeña, L., Tan, A. T. B., Nguyen, T. K., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13950 · Cited by 28
Identification of hub genes in diabetic kidney disease via multiple-microarray analysis
Zhang, Y., Li, W., & Zhou, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-5171 · Cited by 27
Glucose Homeostasis, Hypoglycemia, and the Burnt-Out Diabetes Phenomenon in Kidney Disease
Rhee, C. M., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.03.004 · Cited by 27
Self-citationShestakova, M. V. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh201688684-88 · Cited by 26
Yang, X. X., Zhang, B., Lu, X., Yan, M., Wen, Y., Zhao, T., & Li, P. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1228-4 · Cited by 26
Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes
Kazé, A. D., Jaar, B. G., Fonarow, G. C., & Echouffo-Tcheugui, J. B. (2022) · BMC Medicine · doi:10.1186/s12916-022-02317-0 · Cited by 26
Kiefer, M. K., Finneran, M. M., Ware, C. A., Fareed, N., Joseph, J. J., Thung, S., Costantine, M. M., Landon, M. B., Gabbe, S. G., & Venkatesh, K. K. (2022) · Diabetic Medicine · doi:10.1111/dme.14822 · Cited by 26
Serum Cystatin C Trajectory Is a Marker Associated With Diabetic Kidney Disease
Wang, N., Lu, Z., Zhang, W., Bai, Y., Pei, D., & Li, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.824279 · Cited by 26
Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy
Wei, M., Liu, X., Tan, Z., Tian, X., Li, M., & Wei, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1188003 · Cited by 28
The kidney and type 2 diabetes mellitus: therapeutic implications of SGLT2 inhibitors
Weir, M. R. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1147926 · Cited by 26
Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus
Langhorn, R., Kieler, I. N., Koch, J., Christiansen, L. B., & Jessen, L. R. (2017) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14902 · Cited by 26
A New Chapter for Diabetic Kidney Disease
de Boer, I. H. (2017) · New England Journal of Medicine · doi:10.1056/nejme1708949 · Cited by 26
Kim, J. H., Oh, S. Y., Kim, E. H., Lee, M. J., Jeon, Y. K., Kim, B. H., Kim, J. M., Kim, Y. K., Kim, S. S., & Kim, I. J. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0267-4 · Cited by 25
Barutta, F., Bellini, S., Mastrocola, R., Gambino, R., Piscitelli, F., Marzo, V. D., Corbetta, B., Vemuri, K. V., Makriyannis, A., Annaratone, L., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14495 · Cited by 25
Guo, S., Wang, M., Yu, Y., Yang, Y., Zeng, F., Sun, F., Li, Q., He, M., Li, Y., Wen, J., et al. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00584-7 · Cited by 25
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease
Rhee, C. M., Kalantar‐Zadeh, K., & Tuttle, K. R. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000756 · Cited by 27
Self-citationEmerging drugs for the treatment of diabetic nephropathy
Kim, Y. K., Ning, X., Munir, K. M., & Davis, S. N. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2155632 · Cited by 25
Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease
Yang, Y., Huang, H., Xu, Z., & Duan, J. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7680576 · Cited by 25
Serum cell-free DNA and progression of diabetic kidney disease: a prospective study
Li, X., Hu, R., Luo, T., Peng, C. X., Gong, L., Hu, J., Yang, S., & Li, Q. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001078 · Cited by 25
Kalyani, R. R., Allende-Vigo, M. Z., Antinori-Lent, K. J., Close, K. L., Das, S. R., Deroze, P., Edelman, S. V., El Sayed, N. A., Kerr, D., Neumiller, J. J., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad745 · Cited by 25
Self-citationPonte, C. M. M., Fernandes, V. O., Castelo, M. H. C. G., Vasconcelos, I. T. G. F., Karbage, L. B. D. A. S., Liberato, C. B. R., Negrato, C. A., Gomes, M. B., Montenegro, A. P. D. R., & Montenegro, R. M. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0738-4 · Cited by 24
Zacharias, H. U., Altenbuchinger, M., Schultheiß, U. T., Samol, C., Kotsis, F., Poguntke, I., Sekula, P., Krumsiek, J., Köttgen, A., Spang, R., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00983 · Cited by 24
Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
Mu, X., Yang, M., Ling, P., Wu, A., Zhou, H., & Jiang, J. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s350233 · Cited by 24
Sun, Y., Hong, L., Huang, Z., Wang, L., Xiong, Y., Zong, S., Zhang, R., Liu, J., & Zang, S. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac382 · Cited by 24
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms
Kashihara, N., Kidokoro, K., & Kanda, E. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000561 · Cited by 24
Advances in the management of diabetes: therapies for type 2 diabetes
Tsoutsouki, J., Wunna, W., Chowdhury, A., & Chowdhury, T. A. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2019-137404 · Cited by 24
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE
Liew, A., Bavanandan, S., Prasad, N., Wong, M. G., Chang, J. M., Eiam‐Ong, S., Hao, C., Lim, C. Y., Lim, S. K., Oh, K., et al. (2020) · Nephrology · doi:10.1111/nep.13785 · Cited by 24
Feng, S., Gao, Y.-M., Yin, D., Lv, L., Wen, Y., Li, Z., Wang, B., Wu, M., & Liu, B. (2021) · Kidney & Blood Pressure Research · doi:10.1159/000514013 · Cited by 24
Górriz, J. L., Romera, I., Cobo, A., O’Brien, P. D., & Merino-Torres, J. F. (2022) · Diabetes Therapy · doi:10.1007/s13300-021-01198-5 · Cited by 25
Lu, C., Liu, W., Chen, Z., Hua, L.-Y., Wang, X., & Huang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.888599 · Cited by 23
Fu, S., Cheng, Y., Wang, X., Huang, J., Su, S., Wu, H., Yu, J., & Xu, Z. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.918657 · Cited by 23
Dapagliflozin alleviates renal podocyte pyroptosis via regulation of the HO‑1/NLRP3 axis
Zhang, Z., Ni, P., Tang, M., Song, Y., Liu, C., & Zhao, B. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13087 · Cited by 23
Donate‐Correa, J., Ferri, C. M., Fernández, C. M., Pérez‐Delgado, N., González-Luis, A., & Navarro‐González, J. F. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02393-x · Cited by 23
Management of anemia in patients with diabetic kidney disease: A consensus statement
Kumar, S., Bajaj, S., Makkar, B. M., Abichandani, V. K., Talwalkar, P., Saboo, B., Srikanta, S., Das, A. K., Chandrasekaran, S., Krishnan, P., et al. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.176348 · Cited by 24
Diamantidis, C. J., Bosworth, H. B., Oakes, M. M., Davenport, C. A., Pendergast, J., Patel, S., Moaddeb, J., Barnhart, H. X., Merrill, P. D., Baloch, K. N., et al. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.04.003 · Cited by 23
Self-citationBruyne, S. D., Dorpe, J. V., Himpe, J., Biesen, W. V., Delanghe, S. E., Speeckaert, M. M., & Delanghe, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071022 · Cited by 23
Gor, D., Gerber, B. S., Walton, S. M., Lee, T. A., Nutescu, E. A., & Touchette, D. R. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.13003 · Cited by 24
Blood lead, vitamin D status, and albuminuria in patients with type 2 diabetes
Wang, B., Wan, H., Cheng, J., Chen, Y., Wang, Y., Chen, Y., Chen, C., Zhang, W., Xia, F., Wang, N., et al. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.116653 · Cited by 23
Integration of Chronic Kidney Disease Prevention into Noncommunicable Diseases Programs in Cuba
López, M. A., Valdés, R. H., Díaz, J. P. O., & Rodríguez, O. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804311-0.00034-0 · Cited by 22
The Risk Threshold for Hemoglobin A1c Associated With Albuminuria: A Population-Based Study in China
Lian, H., Wu, H., Ning, J., Lin, D., Huang, C., Li, F., Liang, Y. J., Qi, Y., Ren, M., Yan, L., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.673976 · Cited by 22
Risk of Incident Heart Failure in Individuals With Early-Onset Type 2 Diabetes
Liu, J., Liu, S., Wang, J., Lee, J., Tang, J. I.-S., Gurung, R. L., Ang, K., Shao, Y. M., Subramaniam, T., Tang, W. E., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab620 · Cited by 22
Lin, C., Lai, Y.-C., Chang, T., Jiang, Y., Chang, Y., & Chuang, L. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109834 · Cited by 22
Ren, Q., Chen, D., Liu, X., Yang, R., Yuan, L.-S., Ding, M., & Zhang, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.825950 · Cited by 22
The Pillars for Renal Disease Treatment in Patients with Type 2 Diabetes
Kearney, J., & Gnudi, L. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051343 · Cited by 22
Vegetarian Nutrition in Chronic Kidney Disease
Narasaki, Y., Kalantar‐Zadeh, K., Rhee, C. M., Brunori, G., & Zarantonello, D. (2023) · Nutrients · doi:10.3390/nu16010066 · Cited by 25
Self-citationParallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy
Tang, S., An, X., Sun, W., Zhang, Y., Yang, C., Kang, X., Sun, Y., Jiang, L., Zhao, X., Gao, Q., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1336123 · Cited by 23
Wang, J., Li, Y., Han, X., Hu, H., Wang, F., Yu, C., Li, X., YANG, K. Y., Yuan, J., Yao, P., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.013 · Cited by 22
Lullo, L. D., Mangano, M., Ronco, C., Bàrbera, V., Pascalis, A. D., Bellasi, A., Russo, D., Iorio, B. R. D., & Cozzolino, M. G. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.005 · Cited by 24
Huang, C., Ting, W., Lo, F., Tsai, J.-D., Sun, F., Chan, C.-I., Chiang, Y.-T., Lin, C., Cheng, B.-W., Wu, Y., et al. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.09.015 · Cited by 22
Chiang, C., Lin, S.-Y., Lin, T., Wang, T., Yeh, H., Chen, J., Tsai, C., Hung, Y.-J., Li, Y., Liu, P., et al. (2018) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2018.01.001 · Cited by 22
Ruggenenti, P. L., Trillini, M., Barlovič, D. P., Cortinovis, M., Pisani, A., Parvanova, A. I., Iliev, I. P., Ruggiero, B., Rota, S., Aparicio, M., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13639 · Cited by 22
Takao, T., Suka, M., Yanagisawa, H., & Kasuga, M. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13265 · Cited by 22
Seo, D. H., Nam, M., Jung, M., Suh, Y. J., Ahn, S. H., Hong, S., & Kim, S. H. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0221 · Cited by 22
Iwase, M., Komorita, Y., Ohkuma, T., Fujii, H., Ide, H., Yoshinari, M., Oku, Y., Higashi, T., Nakamura, U., & Kitazono, T. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108518 · Cited by 22
Lu, F., Fan, J., Li, F., Liu, L., Chen, Z., Tian, Z., Zuo, L., & Yu, D. (2023) · Abdominal Radiology · doi:10.1007/s00261-023-04062-1 · Cited by 21
Ning, J., Xiang, Z., Xiong, C., Zhou, Q., Wang, X., & Zou, H. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s250347 · Cited by 21
Narongkiatikhun, P., Chattipakorn, S. C., & Chattipakorn, N. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17116 · Cited by 21
Exploring molecular targets in diabetic kidney disease
Maruno, S., Tanaka, T., & Nangaku, M. (2022) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.21.251 · Cited by 22
Tomofuji, Y., Ken, S., Kishikawa, T., Shojima, N., Hosoe, J., Inagaki, K., Matsubayashi, S., Ishihara, H., Watada, H., Ishigaki, Y., et al. (2023) · Communications Medicine · doi:10.1038/s43856-022-00231-3 · Cited by 21
Romero, M. J., Lucas, R., Dou, H., Sridhar, S., Czikora, I., Mosieri, E. M., Rick, F. G., Block, N. L., Sridhar, S., Fulton, D. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525520113 · Cited by 21
Lee, J.-E., Min, S. H., Lee, D., Oh, T. J., Kim, K. M., Moon, J. H., Choi, S. H., Park, K. S., Jang, H. C., & Lim, S. K. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.015 · Cited by 21
Novel avenues for drug discovery in diabetic kidney disease
Breyer, M. D., & Kretzler, M. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1398731 · Cited by 21
Haine, A., Haynes, A. G., Limacher, A., Sebastian, T., Saengprakai, W., Fuß, T., & Baumgärtner, I. (2018) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944718756605 · Cited by 21
Miyoshi, H., Kameda, H., Yamashita, K., Nakamura, A., & Kurihara, Y. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13064 · Cited by 21
Blankenburg, M., Fett, A.-K., Eisenring, S., Haas, G., & Gay, A. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1348-4 · Cited by 21
Balasubramaniam, S., Lim, S. L., Goh, L. H., Subramaniam, S., & Tangiisuran, B. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.011 · Cited by 23
van Bommel, E. J. M., Ruiter, D., Muskiet, M. H. A., van Baar, M. J. B., Kramer, M. H. H., Nieuwdorp, M., Joles, J. A., Bjornstad, P., & van Raalte, D. H. (2019) · Diabetes Care · doi:10.2337/dc19-1651 · Cited by 21
Cheng, Y., Shang, J., Liu, D., Xiao, J., & Zhao, Z. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1772294 · Cited by 21
Liu, J., Liu, S., Lee, J., Gurung, R. L., Yiamunaa, M., Ang, K., Shao, Y. M., Choo, R. W. M., Subramaniam, T., Tang, W. E., et al. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02024-z · Cited by 21
Maddaloni, E., Moretti, C., Toro, R. D., Sterpetti, S., Ievolella, M. V., Arnesano, G., Strollo, R., Briganti, S., D’Onofrio, L., Pozzilli, P., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14455 · Cited by 21
Cardio- and reno-protective effects of dipeptidyl peptidase III in diabetic mice
Komeno, M., Pang, X., Shimizu, A., Molla, M. R., Yasuda‒Yamahara, M., Kume, S., Rahman, N. I. A., Soh, J. E. C., Nguyen, L. K. C., Amin, M. K. B. A., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100761 · Cited by 21
Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes
Yun, J., Park, Y., Han, K., Kim, H.-W., Cha, S., Ahn, Y., & Ko, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82838-5 · Cited by 21
Wei, R., Qiao, J., Cui, D., Pan, Q., & Guo, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.883658 · Cited by 20
Pan, Y., Yang, H., Chen, T., Jin, J., Ruan, L., Hu, L., & Chen, L. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2118067 · Cited by 20
Cell-Cycle Dysregulation in the Pathogenesis of Diabetic Kidney Disease: An Update
Deng, B., Song, A., & Zhang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032133 · Cited by 20
Association between thyroid hormones and diabetic kidney disease in Chinese adults
Liu, M., Li, J., Wang, Y.-F., Meng, Y., Cai, Z., Shen, C., Wang, M.-D., Zhao, W., & Niu, W. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01299-1 · Cited by 20
Advances in Chronic Kidney Disease in Africa
Rayner, B. L., Jones, E. S. W., Davidson, B. J., & Wearne, N. (2023) · Applied Sciences · doi:10.3390/app13084924 · Cited by 20
Ferdinand, K. C., Norris, K. C., Rodbard, H. W., & Trujillo, J. M. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01464-8 · Cited by 20
Fang, Y., Wang, B., Pang, B., Zhou, Z., Xing, Y., Pang, P., Zheng, D., Zhang, G., & Yang, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-53567-2 · Cited by 21
Qiu, J., Li, Z., Qin, Y., Yue, Y., & Liu, Y.-P. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s123008 · Cited by 20
Mengozzi, A., Carli, F., Biancalana, E., Latta, V. D., Seghieri, M., Gastaldelli, A., & Solini, A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01797 · Cited by 20
Prescription Opioid Use Among Patients With Acute Gout Discharged From the Emergency Department
Dalal, D. S., Mbuyi, N., Shah, I., Reinert, S. E., Hilliard, R., & Reginato, A. M. (2019) · Arthritis Care & Research · doi:10.1002/acr.23928 · Cited by 20
Schroeder, E. B., Powers, J. D., O’Connor, P. J., Nichols, G. A., Xu, S., Desai, J. R., Karter, A. J., Morales, L. S., Newton, K. M., Pathak, R. D., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.04.007 · Cited by 19
Interrelation of Natural Polyphenol and Fibrosis in Diabetic Nephropathy
Ma, Y., Wang, J., Fan, J., Jia, H., & Li, J. (2024) · Molecules · doi:10.3390/molecules30010020 · Cited by 19
Advances in the management of diabetes: new devices for type 1 diabetes
Wunna, W., Tsoutsouki, J., Chowdhury, A., & Chowdhury, T. A. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138016 · Cited by 21
Yao, M., Zhang, D., Fan, J.-T., Lin, K., Haroon, S. M., Jackson, D., Li, H., Chen, W., Cheng, K. K., & Lehman, R. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01632-y · Cited by 19
Fu, Y., Wang, X., Zhang, L., Ren, Y., & Hao, L. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.04.089 · Cited by 19
Economic Evaluations of Screening Programs for Chronic Kidney Disease: A Systematic Review
Rokhman, M. R., Alkaff, F. F., van Dorst, P. W. M., Thobari, J. A., Postma, M. J., van der Schans, J., & Boersma, C. (2023) · Value in Health · doi:10.1016/j.jval.2023.08.003 · Cited by 19
The Potential of Huangqi Decoction for Treating Diabetic Kidney Disease
Chen, Y., Liu, Y., & Cao, A. (2024) · Integrative Medicine in Nephrology and Andrology · doi:10.1097/imna-d-23-00020 · Cited by 19
Żyłka, A., Gala‐Błądzińska, A., Dumnicka, P., Ceranowicz, P., Kuźniewski, M., Gil, K., Olszanecki, R., & Kuśnierz‐Cabala, B. (2016) · Disease Markers · doi:10.1155/2016/8489543 · Cited by 19
Feng, C., Minxiang, W., Chen, Z., Yu, X., Nie, Z., Zhao, Y. C., & Bao, B. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02112-6 · Cited by 20
Shih, H., Chuang, S., Lee, C., Liu, S.-C., & Tsai, M.-C. (2020) · Scientific Reports · doi:10.1038/s41598-020-63967-9 · Cited by 20
Insulin use in chronic kidney disease and the risk of hypoglycemic events
Grube, D., Wei, G., Boucher, R. E., Abraham, N., Zhou, N., Gonce, V., Carle, J., Simmons, D. L., & Beddhu, S. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02687-w · Cited by 19
Metadata
- Authors
- Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., Neumiller, J. J., Patel, U. D., Ratner, R. E., Whaley-Connell, A. T., & Molitch, M. E.
- Affiliations
- University of Washington (US)
- National Kidney Foundation (US)
- Newcastle University (GB)
- American Diabetes Association (US)
- Division of Nephrology, University of Washington, Seattle, WA
- Sierra Nevada Nephrology Consultants, Reno, NV
- School of Medicine, University of California, Irvine, Irvine, CA
- National Institutes of Health (US)
- Cleveland Clinic (US)
- Washington State University Spokane (US)
- Duke University (US)
- Harry S. Truman Memorial Veterans Hospital, Columbia, MO, and Department of Internal Medicine, Division of Nephrology and Hypertension, University of Missouri School of Medicine, Columbia, MO
- Northwestern University (US)
- Corresponding author
- Chiang, Jane L.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-09-10
- Volume
- 37
- Issue
- 10
- Pages
- 2864-2883
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC4170131
- OpenAlex
- W2072070798
- Semantic Scholar
- 0c6864a569d8918ea51eda33aae122cff819ac65
- Cited by
- 1,153
- References
- 193
- Citations by year
- 2026: 90 · 2025: 104 · 2024: 107 · 2023: 131 · 2022: 128 · 2021: 118 · 2020: 130 · 2019: 87 · 2018: 87 · 2017: 72 · 2016: 65 · 2015: 27 · 2014: 6
- FWCI
- 44.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Gilead Sciences
- Halozyme
- Luitpold Pharmaceuticals
- Angion
- Novo Nordisk
- CSL Limited
- National Institutes of Health (UL1TR000430)
- Relypsa
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- diabetic nephropathy, end-stage renal disease, type 2 diabetes, chronic kidney disease, cardiovascular disease, dyslipidemia, hypertension, renin-angiotensin-aldosterone system blockade, mineralocorticoid receptor antagonists, glycemic control, hypoglycemia, pharmacotherapy, pediatric diabetes, multidisciplinary care, patient-centered medical home, health care delivery
- MeSH terms
- Adolescent, Aged, Antihypertensive Agents, Blood Glucose, Cardiovascular Diseases, Child, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Humans, Kidney Function Tests, Middle Aged, Incidence, Prevalence, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
